MEDICOX (054180)

KOSDAQ · 2,295 KRW · As of Aug 26, 2026 close
Mkt Cap
12.7B
Rev (2025)
28.2B
Op Inc (2025)
-5.7B
Net Inc (2025)
-11.9B
PBR
0.27
52W
2K~2K

MEDICOX operates in the Transportation Equipment sector.

Legal name: MEDICOX Co., Ltd.

In fiscal year 2025, MEDICOX (054180) reported revenue of 28.2 billion KRW, down 8.0% from 30.6 billion KRW a year earlier.

Operating profit was -5.7 billion KRW and net income was -11.9 billion KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 12.7 billion KRW, with a P/B of 0.27.

These figures can be verified in the DART filing (receipt no. 20260324000120).

Financials

YearRevOp IncNet Inc
202528.2B-5.7B-11.9B
202430.6B-10.0B-21.4B
202326.9B-10.7B-34.4B

Full financials →

Checks

6 applicable out of 8 items

Check details →

Recent Filings

Meeting Resolution (Extraordinary Meeting)

Short-term Borrowing Decision

Guarantee Decision

All filings →

Checks

6 of 8 checked items currently applicable.

Market Cap & Price: Market cap is below the delisting threshold for 302 consecutive days.
Administrative Designation: 1 administrative designation criteria met. [source]
Audit Opinion: Audit opinion: Disclaimer of opinion. [source]
Convertible Bonds: Convertible bonds outstanding with 0.5% potential dilution.

Capital Increase: No capital-increase filings in the last 180 days.

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: 3 embezzlement/litigation filing(s) in the last 180 days. [source]

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 6 market action(s) (trading halt, delisting, etc.) recorded. [source]
These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Recent Filings

DateFiling
2026-08-27Meeting Resolution (Extraordinary Meeting)
2026-08-26Short-term Borrowing Decision
2026-08-19Guarantee Decision
2026-08-19Collateral Provision Decision
2026-08-14Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)